Target intelligence / Profile preview

Inflammatory cytokine network and associated signaling pathways

Molecular classification
Cytokine, Receptor, Enzyme (Kinase), Transcription factor
01

Overview

The inflammatory cytokine network is a sophisticated system of intercellular signaling proteins, including interleukins, interferons, and tumor necrosis factors, that coordinate the body's immune and inflammatory responses (Source: StatPearls, "Cytokines"). These molecules bind to specific high-affinity cell-surface receptors, triggering intracellular signaling cascades such as the Janus kinase/signal transducer and activator of transcription (JAK/STAT), nuclear factor-kappa B (NF-κB), and mitogen-activated protein kinase (MAPK) pathways (Source: Nature Reviews Immunology). While essential for host defense and tissue repair, chronic dysregulation of this network is a hallmark of autoimmune diseases, such as rheumatoid arthritis and inflammatory bowel disease, as well as systemic conditions like cytokine release syndrome (Source: PubMed, "Targeting cytokine signaling"). Therapeutic strategies focus on modulating this network by using monoclonal antibodies to neutralize specific cytokines or small molecules to inhibit downstream signaling enzymes, thereby restoring immune homeostasis (Source: NIH, "Cytokines and Inflammation").

Other names
Cytokine signaling networkInflammatory cascadeCytokine-mediated signaling pathwaysImmune cell communication network
02

Mechanism of action

Inhibition of specific cytokine-receptor interactions or blockade of downstream intracellular signaling components (e.g., JAK kinases) to dampen the inflammatory response.

03

Biological functions

Immune responseSignal transductionInflammationCell proliferationApoptosisHematopoiesis
04

Disease associations

Autoimmune diseaseCancerInfectionChronic inflammationCardiovascular diseaseNeurodegenerative disease
05

Safety considerations

Increased risk of serious infectionsOpportunistic infections (e.g., Tuberculosis)Malignancy risk (e.g., Lymphoma)CytopeniaInjection site or infusion reactions
06

Interacting drugs

6 more in the full profile.

07

Biomarkers

C-reactive protein (CRP)Interleukin-6 (IL-6) serum levelsTumor necrosis factor-alpha (TNF-alpha) levelsErythrocyte sedimentation rate (ESR)Phospho-STAT levels

Beyond the preview

Go deeper on Inflammatory cytokine network and associated signaling pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Inflammatory cytokine network and associated signaling pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call